Jamshid Maddahi

Title(s)HS Clinical Professor, Molecular and Medical Pharmacology
SchoolMedicine
vCardDownload vCard
    Other Positions
    Title(s)HS Clinical Professor, Medicine


    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. 18F-flurpiridaz positron emission tomography segmental and territory myocardial blood flow metrics: incremental value beyond perfusion for coronary artery disease categorization. Eur Heart J Cardiovasc Imaging. 2022 11 17; 23(12):1636-1644. Packard RRS, Votaw JR, Cooke CD, Van Train KF, Garcia EV, Maddahi J. PMID: 34928321; PMCID: PMC9671402.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    2. Improved myocardial blood flow estimation with residual activity correction and motion correction in 18F-flurpiridaz PET myocardial perfusion imaging. Eur J Nucl Med Mol Imaging. 2022 05; 49(6):1881-1893. Otaki Y, Van Kriekinge SD, Wei CC, Kavanagh P, Singh A, Parekh T, Di Carli M, Maddahi J, Sitek A, Buckley C, Berman DS, Slomka PJ. PMID: 34967914.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    3. Assessing myocardial perfusion in suspected coronary artery disease: rationale and design of the second phase 3, open-label multi-center study of flurpiridaz (F-18) injection for positron emission tomography (PET) imaging. J Nucl Cardiol. 2021 06; 28(3):1105-1116. Bourque JM, Hanson CA, Agostini D, Bateman TM, Bax JJ, Beanlands RSB, Berman DS, Garcia EV, Heller GV, Knuuti J, Tamaki N, Udelson JE, Maddahi J. PMID: 33521873.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    4. Diagnostic Performance of PET Versus SPECT Myocardial Perfusion Imaging in Patients with Smaller Left Ventricles: A Substudy of the 18F-Flurpiridaz Phase III Clinical Trial. J Nucl Med. 2021 06 01; 62(6):849-854. Packard RRS, Lazewatsky JL, Orlandi C, Maddahi J. PMID: 33246979; PMCID: PMC8729859.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    5. Development, diagnostic performance, and interobserver agreement of a 18F-flurpiridaz PET automated perfusion quantitation system. J Nucl Cardiol. 2022 04; 29(2):698-708. Packard RRS, Cooke CD, Van Train KF, Votaw JR, Sayre JW, Lazewatsky JL, Champagne KM, Orlandi C, Garcia EV, Maddahi J. PMID: 32895856; PMCID: PMC7936994.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    6. Phase-III Clinical Trial of Fluorine-18 Flurpiridaz Positron Emission Tomography for Evaluation of Coronary Artery Disease. J Am Coll Cardiol. 2020 07 28; 76(4):391-401. Maddahi J, Lazewatsky J, Udelson JE, Berman DS, Beanlands RSB, Heller GV, Bateman TM, Knuuti J, Orlandi C. PMID: 32703509.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCTClinical Trials
    7. Dosimetry, biodistribution, and safety of flurpiridaz F 18 in healthy subjects undergoing rest and exercise or pharmacological stress PET myocardial perfusion imaging. J Nucl Cardiol. 2019 12; 26(6):2018-2030. Maddahi J, Bengel F, Czernin J, Crane P, Dahlbom M, Schelbert H, Sparks R, Phelps M, Lazewatsky J. PMID: 30488323.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    8. Assessment of left ventricular mass by SPECT MPI. J Nucl Cardiol. 2019 06; 26(3):906-908. Packard RRS, Maddahi J. PMID: 29243071.
      View in: PubMed   Mentions:    Fields:    
    9. PET should replace SPECT in cardiac imaging for diagnosis and risk assessment of patients with known or suspected CAD: Pro. J Nucl Cardiol. 2017 12; 24(6):1955-1959. Maddahi J, Packard RRS. PMID: 28397181.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    10. Regadenoson-induced hyperemia for absolute myocardial blood flow quantitation by 13N-ammonia PET and detection of cardiac allograft vasculopathy. J Nucl Cardiol. 2017 08; 24(4):1145-1148. Packard RRS, Maddahi J. PMID: 28138814.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    11. Proceedings of the ASNC cardiac PET summit meeting, May 12, 2014, Baltimore MD : 5. Advances in radiopharmaceutical availability and development of cardiac PET tracers. J Nucl Cardiol. 2015 Aug; 22(4):730-9. Cerqueira M, Case J, Maddahi J. PMID: 26129941.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    12. Cardiac PET perfusion tracers: current status and future directions. Semin Nucl Med. 2014 Sep; 44(5):333-43. Maddahi J, Packard RR. PMID: 25234078; PMCID: PMC4333146.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansAnimals
    13. Absolute quantitation of myocardial blood flow in human subjects with or without myocardial ischemia using dynamic flurpiridaz F 18 PET. J Nucl Med. 2014 Sep; 55(9):1438-44. Packard RR, Huang SC, Dahlbom M, Czernin J, Maddahi J. PMID: 25071096; PMCID: PMC4315668.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    14. Phase II safety and clinical comparison with single-photon emission computed tomography myocardial perfusion imaging for detection of coronary artery disease: flurpiridaz F 18 positron emission tomography. J Am Coll Cardiol. 2013 Jan 29; 61(4):469-477. Berman DS, Maddahi J, Tamarappoo BK, Czernin J, Taillefer R, Udelson JE, Gibson CM, Devine M, Lazewatsky J, Bhat G, Washburn D. PMID: 23265345; PMCID: PMC4316725.
      View in: PubMed   Mentions: 73     Fields:    Translation:HumansCTClinical Trials
    15. Advances in cardiac imaging: taking a closer look at PET perfusion imaging : American Society of Nuclear Cardiology, Philadelphia, PA, 24 September 2010. J Nucl Cardiol. 2012 Feb; 19 Suppl 1:S46-7. Branscomb E, Heller G, Bateman T, Soman P, Maddahi J, Garcia E, Berman D, DePuey G. PMID: 22147619.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. Properties of an ideal PET perfusion tracer: new PET tracer cases and data. J Nucl Cardiol. 2012 Feb; 19 Suppl 1:S30-7. Maddahi J. PMID: 22259007.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    17. Phase I, first-in-human study of BMS747158, a novel 18F-labeled tracer for myocardial perfusion PET: dosimetry, biodistribution, safety, and imaging characteristics after a single injection at rest. J Nucl Med. 2011 Sep; 52(9):1490-8. Maddahi J, Czernin J, Lazewatsky J, Huang SC, Dahlbom M, Schelbert H, Sparks R, Ehlgen A, Crane P, Zhu Q, Devine M, Phelps M. PMID: 21849402.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansCTClinical Trials
    18. The role of radionuclide myocardial perfusion imaging for asymptomatic individuals. J Nucl Cardiol. 2011 Feb; 18(1):3-15. Hendel RC, Abbott BG, Bateman TM, Blankstein R, Calnon DA, Leppo JA, Maddahi J, Schumaecker MM, Shaw LJ, Ward RP, Wolinsky DG, American Society of Nuclear Cardiology. PMID: 21181519.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    19. The technetium shortage. J Nucl Cardiol. 2010 Dec; 17(6):993-8. Thomas GS, Maddahi J. PMID: 20717761.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    20. Viability assessment with MRI is superior to FDG-PET for viability: Pro. J Nucl Cardiol. 2010 Apr; 17(2):292-7. Maddahi J. PMID: 20225004.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    21. Phantom evaluation of a cardiac SPECT/VCT system that uses a common set of solid-state detectors for both emission and transmission scans. J Nucl Cardiol. 2010 Jun; 17(3):459-69. Bai C, Conwell R, Kindem J, Babla H, Gurley M, De Los Santos R, Old R, Weatherhead R, Arram S, Maddahi J. PMID: 20169476; PMCID: PMC2866957.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    22. Development and evaluation of a new fully automatic motion detection and correction technique in cardiac SPECT imaging. J Nucl Cardiol. 2009 Jul-Aug; 16(4):580-9. Bai C, Maddahi J, Kindem J, Conwell R, Gurley M, Old R. PMID: 19488827; PMCID: PMC2708325.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    23. Prospective multicenter evaluation of rapid, gated SPECT myocardial perfusion upright imaging. J Nucl Cardiol. 2009 May-Jun; 16(3):351-7. Maddahi J, Mendez R, Mahmarian JJ, Thomas G, Babla H, Bai C, Arram S, Maffetone P, Conwell R. PMID: 19247734.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    24. Value of electrocardiographically gated single-photon emission computed tomographic myocardial perfusion scintigraphy in a cohort of symptomatic postmenopausal women. Am J Cardiol. 2007 Apr 15; 99(8):1096-9. Mieres JH, Makaryus AN, Cacciabaudo JM, Donaldson D, Green SJ, Heller GV, Maddahi J, Ong L, Rampersaud T, Rosen SE, Shaw LJ, Katz S. PMID: 17437734.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    25. Cardiovascular disease risk stratification with stress single-photon emission computed tomography technetium-99m tetrofosmin imaging in patients with the metabolic syndrome and diabetes mellitus. Am J Cardiol. 2006 May 15; 97(10):1538-44. Shaw LJ, Berman DS, Hendel RC, Alazraki N, Krawczynska E, Borges-Neto S, Maddahi J, Cerqueira M. PMID: 16679101.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    26. Ethnic differences in the prognostic value of stress technetium-99m tetrofosmin gated single-photon emission computed tomography myocardial perfusion imaging. J Am Coll Cardiol. 2005 May 03; 45(9):1494-504. Shaw LJ, Hendel RC, Cerquiera M, Mieres JH, Alazraki N, Krawczynska E, Borges-Neto S, Maddahi J, Bairey Merz CN. PMID: 15862425.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    27. Factors influencing predictive value of FDG imaging for evaluating myocardial viability. J Nucl Cardiol. 2004 Sep-Oct; 11(5):524-6. Maddahi J. PMID: 15472636.
      View in: PubMed   Mentions:    Fields:    
    28. Preoperative comparison of different noninvasive strategies for predicting improvement in left ventricular function after coronary artery bypass grafting. Am J Cardiol. 2003 Jul 01; 92(1):1-4. Bax JJ, Maddahi J, Poldermans D, Elhendy A, Schinkel A, Boersma E, Valkema R, Krenning EP, Roelandt JR, van der Wall EE. PMID: 12842235.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    29. Prognostic value of normal exercise and adenosine (99m)Tc-tetrofosmin SPECT imaging: results from the multicenter registry of 4,728 patients. J Nucl Med. 2003 Feb; 44(2):134-9. Shaw LJ, Hendel R, Borges-Neto S, Lauer MS, Alazraki N, Burnette J, Krawczynska E, Cerqueira M, Maddahi J, Myoview Multicenter Registry. PMID: 12571200.
      View in: PubMed   Mentions: 68     Fields:    Translation:Humans